ENOV (Enovis) Quality Rank


ENOV Enovis Corp ENOV
60 GF Score
Price $25.22
GF Value $49.63
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Enovis Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Enovis Quality Rank Related Terms

ENOV
60GF Score
Enovis Corp ENOV
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $25.22 is trading 49.2% below its estimated GF Value™ of $49.63. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • Quality Rank:
  • GF Value™: $49.63 vs. price of $25.22 (49.2% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
60GF Score

Get the complete analysis for ENOV

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.22
Price
$49.63
GF Value